Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)
Benitec Biopharma (BNTC) reported Other Non Operating Income of -$89000.0 for Q3 2025, down 195.7% on a YoY basis from $93000.0 in Q3 2024, and up 29.37% sequentially from -$126000.0 in Q2 2025.
Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Other Non Operating Income data on file, last reported at -$89000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income fell 195.7% year-over-year to -$89000.0; the trailing twelve-month figure through Dec 2025 stood at -$215000.0 (up 12.96% YoY), and the FY2025 full-year result was -$131000.0, up 35.78% from the prior year.
- Other Non Operating Income improved to -$89000.0 in Q3 2025, from -$126000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $152000.0 in Q4 2023 to a low of -$507000.0 in Q3 2022.
- A 5-year average of -$85411.8 and a median of -$80000.0 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 380.0% in 2021, while the deepest fall reached 1500.0% in 2021.
- Tracing BNTC's Other Non Operating Income over 5 years: stood at $48000.0 in 2021, then rose by 4.17% to $50000.0 in 2022, then jumped by 204.0% to $152000.0 in 2023, then plunged by 126.32% to -$40000.0 in 2024, then tumbled by 122.5% to -$89000.0 in 2025.
- Business Quant data shows BNTC's Other Non Operating Income at -$89000.0 in Q3 2025, -$126000.0 in Q2 2025, and -$40000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Benitec Biopharma | 530.96 Mn | 530.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 93,000.00 |
| Jun 30, 2024 | -182,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Sep 30, 2023 | -56,000.00 |
| Jun 30, 2023 | -80,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | -507,000.00 |
| Jun 30, 2022 | -50,000.00 |
| Mar 31, 2022 | -29,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | -240,000.00 |
| Jun 30, 2021 | -166,000.00 |
| Mar 31, 2021 | -112,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Sep 30, 2020 | -54,000.00 |
| Jun 30, 2020 | 30,000.00 |